Enterprise Value
-65.74M
Cash
223.2M
Avg Qtr Burn
-39.94M
Short % of Float
4.81%
Insider Ownership
6.84%
Institutional Own.
79.35%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
ITIL-306 Details Cancer, Ovarian cancer, Non-small cell lung carcinoma, Renal cell carcinoma | Phase 1 Data readout | |
ITIL-168 Details Cancer, Melanoma | Failed Discontinued |